Fig. 14

The dual drug loaded LPH preparation consisting of Eto and siCD47 showed better anti-cancer performance than the monotherapy post treatment. The treatment was provided on 2^nd and 7^th day with I-LPHsiNEG, PBS, I-LPHsiCD47, I-LPHsiNEG-Eto,, or I-LPHsiCD47-Eto. (A) Change in body weight (%) during experiment, (B) Representative lung images of different treatment groups, (C) Weight of the individual organ after sacrifice of the mice, (D) Lung tumor nodule count. This figure is reproduced under the terms of the Creative Commons CC BY license. Copyright (2021) John Wiley and Sons [259]